Exploiting the defensive sugars of HIV-1 for drug and vaccine design
The sustained effort towards developing an antibody vaccine against HIV/AIDS has provided much of our understanding of viral immunology. It is generally accepted that one of the main barriers to antibody neutralization of HIV is the array of protective structural carbohydrates that covers the antige...
المؤلفون الرئيسيون: | Scanlan, C, Offer, J, Zitzmann, N, Dwek, R |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Nature Research
2007
|
مواد مشابهة
-
Emerging principles for the therapeutic exploitation of glycosylation.
حسب: Dalziel, M, وآخرون
منشور في: (2014) -
Sugar immunogens
حسب: Dwek, R, وآخرون
منشور في: (2009) -
Antigenic mimicry of the HIV envelope by AIDS-Associated pathogens
حسب: Dunlop, D, وآخرون
منشور في: (2008) -
Antigenic mimicry of the HIV envelope by AIDS-associated pathogens.
حسب: Dunlop, D, وآخرون
منشور في: (2008) -
Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope
حسب: Dunlop, D, وآخرون
منشور في: (2009)